Pharmaceutical Companies Drive Commercial Demand and Clinical...

bir ses eklendi Health

2026-07-30 05:24:07 -

Pharmaceutical Companies Drive Commercial Demand and Clinical Validation

The end-use segmentation of the US 3D Bioprinting Market reveals pharmaceutical companies as the dominant stakeholders, commanding the highest valuation at $321.36 million in 2024. This dominance reflects the pharmaceutical industry's urgent need for more predictive preclinical testing platforms and the substantial research and development budgets these organizations can allocate toward...

0 Yorumlar 0 hisse senetleri 3 Views 0 önizleme